Immuno-oncology is one of the most exciting areas in cancer research today.
— Gursel Aktan, M.D., Ph.D.
associate vice president, Merck Oncology Clinical Research
Merck is at the forefront of research that we hope could change the way cancer is treated.
— Scot Ebbinghaus, M.D.
executive director, Merck Oncology Clinical Research
We're commited to accelerating every step in the journey from lab to clinic.
— David Kaufman, M.D., Ph.D.
director, Merck Oncology Clinical Research